Related Experiment Video
Updated: Aug 4, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Ventricular Arrhythmia Suppression by Magnesium Treatment after Coronary Artery Bypass Surgery
1Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
Insights
Intravenous magnesium sulfate administration effectively reduces ventricular arrhythmias following coronary artery bypass grafting (CABG). This treatment helps correct the common postoperative decline in serum magnesium levels, improving patient outcomes.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Clinical Pharmacology
Background:
- Ventricular arrhythmias are common after coronary artery bypass grafting (CABG).
- Postoperative hypomagnesemia frequently occurs in CABG patients.
- A potential link exists between low magnesium levels and ventricular arrhythmias post-CABG.
Purpose of the Study:
- To investigate if the decline in serum magnesium levels causes ventricular arrhythmias after CABG.
- To determine if intravenous magnesium administration can reduce the incidence of these arrhythmias.
Main Methods:
- A randomized controlled trial involving 140 CABG patients.
- Patients received either 70 mmol of magnesium sulfate or a placebo over two days.
- Arrhythmias were monitored using 48-hour Holter recordings on the third postoperative day.
Main Results:
- Magnesium sulfate administration significantly increased serum magnesium levels compared to placebo (1.09 vs 0.77 mmol/l).
- The incidence of ventricular premature complexes (VPCs) was reduced in the magnesium group (4 vs 12 VPCs/h).
- Complex ventricular arrhythmias (Lown grade 2-5) were significantly less frequent in patients receiving magnesium (19% vs 41%).
Conclusions:
- Correcting the postoperative decline in serum magnesium concentration reduces early VPCs and complex ventricular arrhythmias after CABG.
- Patients with extensive coronary artery disease and those on preoperative diuretic therapy may benefit most from magnesium treatment.
Abstract:
Ventricular arrhythmias occur frequently shortly after coronary artery bypass grafting (CABG), and their occurrence coincides with the postoperative decline in serum magnesium (Mg) levels. To examine if this decline causes ventricular arrhythmias and if their appearance could be reduced by intravenous Mg administration, 140 consecutive CABG patients were randomized to receive 70 mmol of Mg sulphate (N = 69) or placebo (N = 71) over two days. Serum Mg concentration fell to 0.77 mmol/l in the control group but rose to 1.09 mmol/l in the Mg group (p < 0.001). On 48 h Holter, the number of ventricular premature complexes (VPC) on the third postoperative day was reduced in the Mg group (4 +/- 5 vs 12 +/- 21 VPCs/h; p < 0.05) and the incidence of complex ventricular arrhythmias (Lown grade 2-5) was significantly diminished (19% vs 41% of the patients; p < 0.05). In multivariate analysis, high risk ventricular arrhythmias (repetitive polymorphic ventricular complexes, couplets, R-on-T complexes or operative tachycardia) were independently predicted by high number of bypassed vessels (p = 0.01), poor NYHA functional class (p = 0.06), preoperative diuretic use (p = 0.07), and low postoperative Mg levels (p = 0.08). In conclusion, correction of the postoperative decline in serum Mg concentration decreases the occurrence of early VPCs and complex ventricular arrhythmias. Patients with extensive underlying coronary artery disease and prior diuretic therapy appear to benefit greatest from Mg treatment.http://link.springer-ny.com/link/service/journals/00547/bibs/8n3p165.html
Related Concept Videos
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Heart Failure Drugs: Inotropic Agents
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias VI: Management of Dysrhythmias
Cardiopulmonary Resuscitation IV: Pharmacological Management
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

